Bcl-xL Is Required by Primary Hippocampal Neurons during Development to Support Local Energy Metabolism at Neurites

B-cell lymphoma-extra large (Bcl-xL) is a mitochondrial protein known to inhibit mitochondria-dependent intrinsic apoptotic pathways. An increasing number of studies have demonstrated that Bcl-xL is critical in regulating neuronal energy metabolism and has a protective role in pathologies associated...

Full description

Bibliographic Details
Published in:	Biology
Main Authors:	Joseph Jansen, Madison Scott, Emma Amjad, Allison Stumpf, Kimberly H. Lackey, Kim A. Caldwell, Han-A Park
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Subjects:	Bcl-xL mitochondria motility ATP neurite
Online Access:	https://www.mdpi.com/2079-7737/10/8/772

Similar Items

Anti‐apoptotic protein BCL‐XL as a therapeutic vulnerability in gastric cancer
by: Yumin Wei, et al.
Published: (2023-06-01)

Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy
by: Mike-Andrew Westhoff, et al.
Published: (2022-01-01)

Infectious Spleen and Kidney Necrosis Virus (ISKNV) Triggers Mitochondria-Mediated Dynamic Interaction Signals via an Imbalance of Bax/Bak over Bcl-2/Bcl-xL in Fish Cells
by: Pin-Han Chen, et al.
Published: (2022-04-01)

Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function
by: Atenea A. Perez-Serna, et al.
Published: (2025-01-01)

Bax mitochondrial relocation is linked to its phosphorylation and its interaction with Bcl-xL
by: David Garenne, et al.
Published: (2016-12-01)

Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment
by: Anna Maria Lucianò, et al.
Published: (2023-07-01)

MDM2-BCL-XL PROTACs enable degradation of BCL-XL and stabilization of p53
by: Mengyang Chang, et al.
Published: (2022-08-01)

Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer
by: Dimitrios E. Magouliotis, et al.
Published: (2022-11-01)

Bcl‐2/Bcl‐xl inhibitor APG‐1252‐M1 is a promising therapeutic strategy for gastric carcinoma
by: Hanjie Yi, et al.
Published: (2020-06-01)

PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer
by: Sajid Khan, et al.
Published: (2024-03-01)

Bcl-xL Reduces Chinese Giant Salamander Iridovirus-Induced Mitochondrial Apoptosis by Interacting with Bak and Inhibiting the p53 Pathway
by: Yiqun Li, et al.
Published: (2021-11-01)

Molecular docking approach to identify Bcl-xL inhibitory effect of sesquiterpene coumarins of Ferula species
by: Fadıl Kaan Kuran, et al.
Published: (2025-05-01)

Reinstating apoptosis using putative Bcl-xL natural product inhibitors: Molecular docking and ADMETox profiling investigations
by: Ibrahim Damilare Boyenle, et al.
Published: (2023-06-01)

Clearance of therapy‐induced senescent tumor cells by the senolytic ABT‐263 via interference with BCL‐XL–BAX interaction
by: Tareq Saleh, et al.
Published: (2020-10-01)

RHAMMB-mediated bifunctional nanotherapy targeting Bcl-xL and mitochondria for pancreatic neuroendocrine tumor treatment
by: Xiang Chen, et al.
Published: (2021-12-01)

Bcl-xL/Bak interaction and regulation by miRNA let-7b in the intrinsic apoptotic pathway of stored platelets
by: Yuzhong Yan, et al.
Published: (2019-01-01)

Targeting entry into mitochondria for increased anticancer efficacy of BCL-XL-selective inhibitors in lung cancer
by: Liangping Li, et al.
Published: (2022-03-01)

Bax- Bcl-xL interaction dynamics during the progression of cell cycle and cell death using FLIM-FRET
by: Aman Munirpasha Halikar, et al.
Published: (2025-07-01)

Quantifying the inhibitory effect of Bcl‐xl on the action of Mff using live‐cell fluorescence imaging
by: Yunyun Ma, et al.
Published: (2019-12-01)

Quiescent OXPHOS-High Triple-Negative Breast Cancer Cells That Persist After Chemotherapy Depend on BCL-XL for Survival
by: Slawomir Andrzejewski, et al.
Published: (2025-10-01)

20(S)-protopanaxadiol inhibits proliferation and induces apoptosis of acute myeloid leukemia cells via targeting Bcl-XL and MCL-1
by: Meng Xu, et al.
Published: (2025-04-01)

YAP activation in Müller cells protects against NMDA-induced retinal ganglion cell injury by regulating Bcl-xL expression
by: Toshihide Kashihara, et al.
Published: (2024-08-01)

Bcl-xL regulates radiation-induced ferroptosis through chaperone-mediated autophagy of GPX4 in tumor cells
by: Jing Han, et al.
Published: (2024-06-01)

Doxorubicin Changes Bax /Bcl-xL Ratio, Caspase-8 and 9 in Breast Cancer Cells
by: Simin Sharifi, et al.
Published: (2015-09-01)

Bcl-xL Is Spontaneously Inserted into Preassembled Nanodiscs and Stimulates Bax Insertion in a Cell-Free Protein Synthesis System
by: Akandé Rouchidane Eyitayo, et al.
Published: (2023-05-01)

Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13‐Mediated Stabilization of Bcl‐XL
by: Hao Yan, et al.
Published: (2023-09-01)

<i>Bcl</i>-<i>xL</i> Promotes the Survival of Motor Neurons Derived from Neural Stem Cells
by: Yunqin Wu, et al.
Published: (2023-01-01)

SIRT5: A Safeguard Against Oxidative Stress-Induced Apoptosis in Cardiomyocytes
by: Ban Liu, et al.
Published: (2013-10-01)

Blockade of the STAT3/BCL-xL Axis Leads to the Cytotoxic and Cisplatin-Sensitizing Effects of Fucoxanthin, a Marine-Derived Carotenoid, on Human Bladder Urothelial Carcinoma Cells
by: Wen-Chyi Dai, et al.
Published: (2025-01-01)

Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity
by: Daria Galas-Filipowicz, et al.
Published: (2024-04-01)

Co-targeting of epigenetic regulators and BCL-XL improves efficacy of immune checkpoint blockade therapy in multiple solid tumors
by: Yaiza Senent, et al.
Published: (2025-05-01)

MiR-4270 acts as a tumor suppressor by directly targeting Bcl-xL in human osteosarcoma cells
by: Clément Veys, et al.
Published: (2023-08-01)

DLBCL Cells with Acquired Resistance to Venetoclax Are Not Sensitized to BIRD-2 But Can Be Resensitized to Venetoclax through Bcl-XL Inhibition
by: Martijn Kerkhofs, et al.
Published: (2020-07-01)

Dimethyl fumarate abrogates hepatocellular carcinoma growth by inhibiting Nrf2/Bcl-xL axis and enhances sorafenib’s efficacy
by: Oluwasijibomi Damola Faleti, et al.
Published: (2025-05-01)

Mast cell tryptase-PAR2 axis promotes ovarian fibrosis through RNF152-mediated stabilization of Bcl-xL.
by: Xiang Zhang, et al.
Published: (2025-06-01)

Bcl-xl基因对硝普钠诱导SY5Y细胞凋亡的抑制作用
by: 杨炼红, et al.
Published: (2012-01-01)

Yeast as a tool for studying proteins of the Bcl-2 family
by: Peter Polčic, et al.
Published: (2015-03-01)

Exploration of Multiconformers to Extract Information About Structural Deformation Undergone by a Protein Target: Illustration on the Bcl-xL Target
by: Marine Baillif, et al.
Published: (2025-08-01)

In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model
by: Phuoc Vinh Nguyen, et al.
Published: (2022-12-01)

Targeting BCL-2 family proteins using BH3 mimetic drugs for cancer therapy: A systematic review of randomized clinical trials
by: Fatimah Alharbi, et al.
Published: (2024-12-01)